{"id":263139,"date":"2026-09-23T10:01:52","date_gmt":"2026-09-23T04:31:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263139"},"modified":"2026-09-23T10:01:52","modified_gmt":"2026-09-23T04:31:52","slug":"amrutanjan-health-care-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/amrutanjan-health-care-best-stock-in-its-sector\/","title":{"rendered":"Is Amrutanjan Health Care the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Amrutanjan Health Care CMP Rs 500 (23 Sep 2026). Market cap Rs 1,446 Cr. ROE 17.42%. P\/E 26.79x versus Industry P\/E 51.81x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Amrutanjan Health Care is one of the names investors compare when screening the FMCG sector, built on a 17.42% return on equity and a P\/E of 26.79x against an Industry P\/E of 51.81x. Whether Amrutanjan Health Care is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named FMCG sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Amrutanjan Health Care<\/a> the best stock in its sector? The stock trades on the NSE at Rs 500 as of 23 September 2026, within its 52-week range of Rs 476.50 to Rs 772.00. Amrutanjan Health Care Ltd markets pain relief balms and over-the-counter healthcare products under the Amrutanjan brand.<\/p>\n

Amrutanjan Health Care sits in the FMCG sector, and its 17.42% ROE and 26.79x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n